163 related articles for article (PubMed ID: 181701)
1. Mass screening for breast disease. Results, problems, and expectations.
Schwartz GF; Feig SA; Libshitz HI; Patchefsky AS; Nerlinger RE; Wallace JD
Obstet Gynecol; 1976 Aug; 48(2):137-41. PubMed ID: 181701
[TBL] [Abstract][Full Text] [Related]
2. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
[TBL] [Abstract][Full Text] [Related]
3. The use of state-of-the-art mammography in the detection of nonpalpable breast carcinoma.
Kaplan C; Matallana R; Wallack MK
Am Surg; 1990 Jan; 56(1):40-2. PubMed ID: 2153010
[TBL] [Abstract][Full Text] [Related]
4. The detection and diagnosis of early, occult and minimal breast cancer.
Hickey RC; Gallager HS; Dodd GD; Samuels BI; Paulus DD; Moore DL
Adv Surg; 1976; 10():287-312. PubMed ID: 185891
[TBL] [Abstract][Full Text] [Related]
5. Occult lesions of the breast.
Poole GV; Choplin RH; Sterchi JM; Leinbach LB; Myers RT
Surg Gynecol Obstet; 1986 Aug; 163(2):107-10. PubMed ID: 3016925
[TBL] [Abstract][Full Text] [Related]
6. In situ ductal carcinoma of the breast--analysis of clinical presentation and outcome in 156 consecutive cases.
Ciatto S; Grazzini G; Iossa A; Del Turco MR; Bravetti P; Cataliotti L; Cardona G; Bianchi S
Eur J Surg Oncol; 1990 Jun; 16(3):220-4. PubMed ID: 2161353
[TBL] [Abstract][Full Text] [Related]
7. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
Ringberg A; Andersson I; Aspegren K; Linell F
Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the contralateral breast in patients with ipsilateral breast carcinoma: the role of mammography.
Muttarak M; Pojchamarnwiputh S; Padungchaichote W; Chaiwun B
Singapore Med J; 2002 May; 43(5):229-33. PubMed ID: 12188073
[TBL] [Abstract][Full Text] [Related]
9. Implications of suspicious findings in breast cancer screening.
Lewis JD; Milbrath JR; Shaffer KA; Das Gupta TK
Arch Surg; 1975 Aug; 110(8):903-7. PubMed ID: 168837
[TBL] [Abstract][Full Text] [Related]
10. How good is thermography in breast cancer screening?
Feig SA
Am Fam Physician; 1975 Dec; 12(6):78-82. PubMed ID: 173168
[TBL] [Abstract][Full Text] [Related]
11. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
[TBL] [Abstract][Full Text] [Related]
12. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
Sakorafas GH; Tsiotou AG
Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
[TBL] [Abstract][Full Text] [Related]
13. Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia.
Port ER; Park A; Borgen PI; Morris E; Montgomery LL
Ann Surg Oncol; 2007 Mar; 14(3):1051-7. PubMed ID: 17206485
[TBL] [Abstract][Full Text] [Related]
14. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.
Goyal A; Douglas-Jones A; Monypenny I; Sweetland H; Stevens G; Mansel RE
Breast Cancer Res Treat; 2006 Aug; 98(3):311-4. PubMed ID: 16552627
[TBL] [Abstract][Full Text] [Related]
15. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis of breast cancer in the clinical stage T1].
Bartl W; Euller A; Pfersmann C; Bernaschek G; Breitenecker G
Wien Klin Wochenschr; 1984 Oct; 96(19):722-7. PubMed ID: 6098079
[TBL] [Abstract][Full Text] [Related]
17. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.
Monti S; Galimberti V; Trifiro G; De Cicco C; Peradze N; Brenelli F; Fernandez-Rodriguez J; Rotmensz N; Latronico A; Berrettini A; Mauri M; Machado L; Luini A; Paganelli G
Ann Surg Oncol; 2007 Oct; 14(10):2928-31. PubMed ID: 17674108
[TBL] [Abstract][Full Text] [Related]
18. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
Kriege M; Brekelmans CT; Boetes C; Muller SH; Zonderland HM; Obdeijn IM; Manoliu RA; Kok T; Rutgers EJ; de Koning HJ; Klijn JG;
Cancer; 2006 Jun; 106(11):2318-26. PubMed ID: 16615112
[TBL] [Abstract][Full Text] [Related]
19. [Circumstances in the detection of carcinoma in situ of the breast. Apropos of 12 cases].
Pangui E; Chevrant-Breton O; Berrada A; Philippe HJ; Kerisit J; Giraud JR; Grall JY
J Gynecol Obstet Biol Reprod (Paris); 1988; 17(4):491-4. PubMed ID: 2850312
[TBL] [Abstract][Full Text] [Related]
20. [Mammography and ultrasound in the diagnosis of clinically occult breast cancer].
Gyr T; Almendral AC; Meier D
Gynakol Rundsch; 1989; 29(2):65-8. PubMed ID: 2544492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
